| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |